Raymond James Financial Services Advisors, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 109,545 shares of MIRM stock, worth $5.82 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
109,545
Previous 98,883
10.78%
Holding current value
$5.82 Million
Previous $3.38 Million
26.39%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$349 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$244 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$172 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$149 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$139 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.95B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...